Clinic Directory — coming soon. Are you an Australian peptide clinic?Apply to be listed →
Independent · Australian · Education only — not medical adviceAboutEditorial standardsHow we review
HomeEncyclopediaVIP

VIP

Vasoactive intestinal peptide

Research / unapproved

What it is

A naturally occurring signalling peptide with roles in inflammation and the airways, studied in research contexts.

What the evidence shows

An active research area; no robust evidence base for the wellness uses marketed online.

Safety & reported risks

Unregulated supply with unknown quality and no established human safety profile for marketed uses.

Status in Australia

Not an approved consumer medicine in Australia; a related compound (aviptadil) has been investigational.

How it’s lawfully accessed

No lawful consumer supply for marketed uses. Not a registered consumer medicine.

Related peptides

Thymosin Alpha-1Immune-modulating peptideCompounded useOxytocinEndogenous peptide hormonePrescription medicine

Sources & further reading

This entry is general information about VIP, not a recommendation to use it. We don’t provide dosing, protocols or sourcing. Speak to a registered practitioner.

Written by The Peptides.au editorial team
Editorial review Checked against current TGA, ARTG and AHPRA public guidance
Last updated 1 June 2026

This is general education, not medical advice. Peptides.au does not sell, supply, recommend or promote any product or clinic. Always speak with a registered Australian health practitioner before making any health decision.